海洋n-3多不饱和脂肪酸与缺血性卒中风险
该研究基于丹麦饮食、癌症与健康队列57 053名50-65岁参与者,基线填写食物频率问卷并采集脂肪组织活检,随访13.5年期间1879人发生缺血性卒中。脂肪组织EPA含量最高与最低四分位相比,总缺血性卒中风险降低(HR 0.74;95%CI 0.62-0.88)。总海洋n-3多不饱和脂肪酸和DHA与心源性栓塞风险升高相关,结论不一致。
要点
- 膳食总海洋n-3多不饱和脂肪酸、EPA和DHA及脂肪组织EPA与较低的大动脉粥样硬化风险相关。
- 膳食总海洋n-3多不饱和脂肪酸和DHA及脂肪组织总海洋n-3多不饱和脂肪酸和DHA与心源性栓塞风险升高相关。
核心结论
- EPA与多数类型缺血性卒中风险降低相关,心源性栓塞除外。
- 总海洋n-3多不饱和脂肪酸和DHA与缺血性卒中的关联不一致。
研究设计与样本
- 丹麦饮食、癌症与健康队列,57 053名50-65岁参与者,基线填写食物频率问卷并采集脂肪组织活检。
- 随访13.5年,1879人发生缺血性卒中,病例经丹麦国家患者登记处验证。
- 病例和3203名随机样本通过气相色谱测定脂肪组织脂肪酸组成。
主要发现
- 脂肪组织EPA最高与最低四分位相比,总缺血性卒中HR 0.74(95%CI 0.62-0.88)。
- 膳食总海洋n-3多不饱和脂肪酸、EPA和DHA及脂肪组织EPA与较低的大动脉粥样硬化风险相关,HR分别为0.69(95%CI 0.50-0.95)、0.66(95%CI 0.48-0.91)、0.72(95%CI 0.53-0.99)和0.52(95%CI 0.36-0.76)。
- 膳食总海洋n-3多不饱和脂肪酸和DHA及脂肪组织总海洋n-3多不饱和脂肪酸和DHA与心源性栓塞风险升高相关,HR分别为2.50(95%CI 1.38-4.53)、2.12(95%CI 1.21-3.69)、2.63(95%CI 1.33-5.19)和2.00(95%CI 1.04-3.84)。
- 脂肪组织EPA与较小血管闭塞风险降低相关(HR 0.69;95%CI 0.55-0.88)。
临床怎么用
- EPA水平较高与多数缺血性卒中亚型风险降低相关,但心源性栓塞风险升高,需个体化评估。
- 海洋n-3多不饱和脂肪酸补充对卒中的预防作用需考虑卒中亚型差异。
局限性
- 观察性研究,不能确定因果关系。
- 脂肪酸测定仅部分病例和随机样本完成。
- 膳食和脂肪组织生物标志物仅基线测量,未反映随访期间变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We hypothesized that total marine n-3 polyunsaturated fatty acids (PUFA), in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the diet and in adipose tissue (biomarkers of long-term intake and endogenous exposure) were inversely associated with the risk of ischemic stroke and its subtypes. Methods- The Diet, Cancer and Health cohort consisted of 57 053 participants aged 50 to 65 years at enrolment. All participants filled in a food frequency questionnaire and had an adipose tissue biopsy taken at baseline. Information on ischemic stroke during follow-up was obtained from The Danish National Patient Register, and all cases were validated. Cases and a random sample of 3203 subjects from the whole cohort had their fatty acid composition of adipose tissue determined by gas chromatography. Results- During 13.5 years of follow-up 1879 participants developed an ischemic stroke. Adipose tissue content of EPA was inversely associated with total ischemic stroke (hazard ratio [HR], 0.74; 95% CI, 0.62-0.88) when comparing the highest with the lowest quartile. Also, lower rates of large artery atherosclerosis were seen with higher intakes of total marine n-3 PUFA (HR, 0.69; 95% CI, 0.50-0.95), EPA (HR, 0.66; 95% CI, 0.48-0.91) and DHA (HR, 0.72; 95% CI, 0.53-0.99), and higher adipose tissue content of EPA (HR, 0.52; 95% CI, 0.36-0.76). Higher rates of cardioembolism were seen with higher intakes of total marine n-3 PUFA (HR, 2.50; 95% CI, 1.38-4.53) and DHA (HR, 2.12; 95% CI, 1.21-3.69) as well as with higher adipose tissue content of total marine n-3 PUFA (HR, 2.63; 95% CI, 1.33-5.19) and DHA (HR, 2.00; 95% CI, 1.04-3.84). The EPA content in adipose tissue was inversely associated with small-vessel occlusion (HR, 0.69; 95% CI, 0.55-0.88). Conclusions- EPA was associated with lower risks of most types of ischemic stroke, apart from cardioembolism, while inconsistent findings were observed for total marine n-3 PUFA and DHA.
引用
- Venø SK, Bork CS, Jakobsen MU, et al. Marine n-3 Polyunsaturated Fatty Acids and the Risk of Ischemic Stroke. Stroke. 2019. PMID: 30602356. doi:10.1161/STROKEAHA.118.023384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。